2022
DOI: 10.1016/j.clnesp.2022.03.016
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of iron-folic acid treatment for reducing anemia prevalence and improving iron status in women of reproductive age: A one-year longitudinal study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 27 publications
0
5
0
1
Order By: Relevance
“…This analysis de ned the Hb response curve to increasing exposures of body iron status (PF or BIS, assuming that folate status was normalized and replete) from a longitudinal analysis of a highly supervised IFA treatment of 90 days, that tested the e cacy of a 'screen and treat' program to achieve anaemia reduction. 11,12 The motivation for the present analysis came from the nding that even though the IFA compliance was high (76%) in this captive study setting for 90 days, the supplementation could not mitigate anaemia completely among a mixed group of anaemic and non-anaemic WRA, in whom a signi cant proportion remained either mild (18.9%) or moderately (10.8%) anaemic. 11 This analysis was agnostic to the type of IFA supplementation, different as it was for anaemic and non-anaemic subjects due to ethical considerations for anaemia treatment/prevention norms, 13 and relied on the change in PF or BIS as the key exposure for Hb change.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This analysis de ned the Hb response curve to increasing exposures of body iron status (PF or BIS, assuming that folate status was normalized and replete) from a longitudinal analysis of a highly supervised IFA treatment of 90 days, that tested the e cacy of a 'screen and treat' program to achieve anaemia reduction. 11,12 The motivation for the present analysis came from the nding that even though the IFA compliance was high (76%) in this captive study setting for 90 days, the supplementation could not mitigate anaemia completely among a mixed group of anaemic and non-anaemic WRA, in whom a signi cant proportion remained either mild (18.9%) or moderately (10.8%) anaemic. 11 This analysis was agnostic to the type of IFA supplementation, different as it was for anaemic and non-anaemic subjects due to ethical considerations for anaemia treatment/prevention norms, 13 and relied on the change in PF or BIS as the key exposure for Hb change.…”
Section: Discussionmentioning
confidence: 99%
“…The PF (# FR248T, Calbiotech, USA), sTfR(# DY2474, R&D systems, USA), hepcidin (#DY8307-05, R&D systems, USA) and C-reactive protein (# DY1707, R&D systems, USA) measurements were performed using their respective ELISA kits, following manufacturer instructions. 11 . The CV of these assays was always < 5%.…”
Section: Blood Analysesmentioning
confidence: 99%
See 1 more Smart Citation
“…The characteristic of the fast food pattern was a high intake of fast food, convenience food, beverages, and sweets, and it was positively associated with the level of anemia in our study. Anemia is closely related to nutrients such as iron [32], protein, vitamin B12, and folic acid [33,34]. About 80% of iron in the body is related to the production of hemoglobin in red blood cells [35,36]; thus, iron deficiency is regarded as the most common " means p-value < 0.05; "+"means p-value < 0.06.…”
Section: Discussionmentioning
confidence: 99%
“…Известно, что усвояемость железа улучшает фолиевая кислота [17]. В ряде исследований было установлено, что противоанемическое действие фармакологической комбинации железа и фолатов превосходит таковое при действии только монопрепаратами железа [18,19]. Фолиевая кислота влияет на биосинтез ДНК в клетках костного мозга; стимулирует эритро-, лейко-и тромбопоэз, поэтому многие лекарственные формы железа содержат ее в средних дозировках.…”
Section: Reproductive Health and Artunclassified